AMLX - Amylyx Pharmaceuticals Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-13    (Delayed quote data   2025-06-30)
Last
 6.41		 Change
 ⇑ +0.08   (+1.26%)		 Volume
  2,126,091
Open
 6.34		 High
 6.57		 Low
 6.26
8EMA (Daily)
 6.05		 40EMA (Daily)
 5.29		 50EMA (Daily)
 5.15		 STO (Daily)
 83.422		 MACD Hist (Daily)
 0.201
8EMA (Weekly)
 5.570		 40EMA (Weekly)
 4.88		 50EMA (Weekly)
 5.24		 STO (Weekly)
 86.009		 MACD Hist (Weekly)
 0.461
Company Profile
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com